It's official: Pfizer and BioNTech have submitted their Covid-19 vaccine to the FDA — and the agency circled a date for the adcomm

Nicole DeFeudis

Editor

Pfizer and BioNTech’s request for emergency authorization of its Covid-19 vaccine is now in the FDA’s hands. Regulators caught the application Friday afternoon in an …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

It's official: Pfizer and BioNTech have submitted their Covid-19 vaccine to the FDA — and the agency circled a date for the adcomm

Nicole DeFeudis

Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

FDA approves first drug to treat ultra-rare lipid storage disease

Will CRISPR matter?

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

It's of­fi­cial: Pfiz­er and BioN­Tech have sub­mit­ted their Covid-19 vac­cine to the FDA — and the agency cir­cled a date for the ad­comm

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

It's official: Pfizer and BioNTech have submitted their Covid-19 vaccine to the FDA — and the agency circled a date for the adcomm